Major study tests new way to screen for cancer risk gene
NCT ID NCT03351803
Summary
This study aims to learn how to offer BRCA gene testing to a larger number of people and make it a regular part of healthcare. It involves over 5,400 adults of Ashkenazi Jewish ancestry who have not had this genetic test before. The research focuses on how people decide to get tested, how they receive results, and the impact of learning their genetic risk.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRCA1 MUTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02115, United States
-
Memorial Sloan - Kettering Cancer Center
New York, New York, 10021, United States
-
University of California, Los Angeles
Los Angeles, California, 90095, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104-4283, United States
Conditions
Explore the condition pages connected to this study.